Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2020-09-25 to 2023-09-24
Current total value of award: $4452838.2
Description: PER SECTION 711 OF THE 2019 NDAA, USAMRAA TRANSFERRED TO DHA 10/1/2022.